Dawson M. A. et al. “AT9283, a potent inhibitor of the Aurora kinases and Jak2, has therapeutic potential in myeloproliferative disorders.” British Journal of Haematology 150, no. 1 2010: 46-57. DOI: 10.1111/j.1365-2141.2010.08175.x.

/in ,

Dawson M. A. et al. “AT9283, a potent inhibitor of the Aurora kinases and Jak2, has therapeutic potential in myeloproliferative disorders.” British Journal of Haematology 150, no. 1 2010: 46-57. DOI: 10.1111/j.1365-2141.2010.08175.x.